Home › Valeant Pharmaceuticals Intl's (VRX) "Hold" Rating Reaffirmed at Mizuho
 

Keywords :   


Valeant Pharmaceuticals Intl's (VRX) "Hold" Rating Reaffirmed at Mizuho

2016-01-04 02:40:05| Biotech - Topix.net

's stock had its "hold" rating reaffirmed by analysts at Mizuho in a research report issued on Sunday, Market Beat reports. An institutional investor recently raised its position in Valeant Pharmaceuticals Intl stock.

Tags: rating hold pharmaceuticals reaffirmed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
More »